MAY 2020 | Newsletter
California Nurse-Midwives Association
Annual Meeting Update
Hello midwife community! We wanted to acknowledge that it remains unclear if holding an Annual meeting in August will be a healthy decision. We are looking at options including a virtual meeting or simply pushing the timing of the meeting to next year given we will all need community coming out of 2020 and this pandemic.
Please know we are looking at our current contract and seeing what our options will be. We will be fully transparent on our decision making, refund decisions and scheduling moving forward. We know many of us look to this meeting with excitement to connect and learn with one another and we acknowledge that changing this is disappointing.
I look forward to sending out more information once we have it and connecting with everyone once it is safe to do so. Thank you all for your continued work caring for pregnant people and their families during this very different time. Stay safe and well.
Work Group to Support the California Nurse Midwifery Foundation
Want a fun, low impact way to contribute to advancing access to midwifery care, diversification of the midwifery workforce, and promoting anti-racism and reproductive justice in maternity care in California? Come support the brand-new California Nurse-Midwives Foundation by joining our working group to support the foundation board. We are a lean group and want to make sure we have more eyes, ears, and hearts participating in review of funding requests and grant proposals. No prior foundation experience required, we only have 1 short monthly meeting per month, and a huge contribution could be made by just giving us 2-5 hours per month of your time. Please reach out to any of the foundation board members Kathleen Belzer (email@example.com), Ana Delgado (firstname.lastname@example.org), or Kavita Noble (email@example.com) if you have questions or to express interest!
Attorney General’s Request for outreach about barriers to abortion care
The office of Xavier Becerra, the California Attorney General, reached out to CNMA to inquire about medication abortion and barriers to access during COVID-19. Because medication abortion (specifically, mifepristone) carries the FDA "REMS" designation, patients must be seen in person to have an examination in order to get the medication. The Attorney General of California led a coalition of 21 attorneys general in sending a letter to the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration (FDA) requesting that they increase access to reproductive healthcare, including safe and legal abortion, during the COVID-19 pandemic. The coalition urged the Administration to waive or utilize its discretion on enforcement of its Risk Evaluation and Mitigation Strategy (REMS) designation, which impedes women’s access to the medication abortion with Mifepristone, so that Telehealth can be better utilized for prescribing of mifepristone. They reached out to us to ask for any specific examples/experiences of barriers to treatment for patients who desire medication abortion during COVID-19. Please contact Holly Smith at firstname.lastname@example.org if you have concerns or have experiences you would like to share.
Join the CNMA Board
CNMA has two NEW Board positions and the Treasurer position that are open for election. Please see below and reach out if you are interested.